Indra Heckenbach, Rita Peila, Christopher Benz, Sheila Weinmann, Yihong Wang, Mark Powell, Morten Scheibye-Knudsen, Thomas Rohan
{"title":"细胞衰老预测乳腺癌的风险从良性乳腺疾病活检图像。","authors":"Indra Heckenbach, Rita Peila, Christopher Benz, Sheila Weinmann, Yihong Wang, Mark Powell, Morten Scheibye-Knudsen, Thomas Rohan","doi":"10.1186/s13058-025-01993-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Each year, millions of women undergo breast biopsies. Of these, 80% are negative for malignancy but some may be at elevated risk of invasive breast cancer (IBC) due to the presence of benign breast disease (BBD). Cellular senescence plays a complex but poorly understood role in breast cancer development and the presence or absence of these cells may have prognostic value.</p><p><strong>Methods: </strong>We conducted a case-control study, nested within a cohort of 15,395 women biopsied for BBD at Kaiser Permanente Northwest between 1971 and 2006. Cases (n = 512) were women who developed a subsequent invasive breast cancer (IBC) at least one year after the BBD biopsy; controls (n = 491) did not develop IBC during the same follow-up period. Using H&E-stained biopsy images, we predicted senescence based on deep learning models trained on replicative senescence (RS), ionizing radiation (IR), and various drug treatments. Age-adjusted and multivariable odds ratios (ORs) and 95% confidence intervals (CI) were estimated using unconditional logistic regression.</p><p><strong>Results: </strong>The RS- and IR-derived senescence scores for adipose tissue and the RS-derived score for epithelial tissue were positively associated with the risk of IBC (adipose tissue - RS model: OR<sub>q4 vs. q1</sub>=1.69, 95% CI 1.03-2.77, and IR model: OR<sub>q4 vs. q1</sub>=1.73, 95%CI 1.06-2.82; epithelial tissue- RS model: OR<sub>q4 vs. q1</sub>=1.53, 95% CI 1.05-2.22). The results were stronger among postmenopausal women and women with epithelial hyperplasia with/without atypia, and postmenopausal women also showed a positive association for stromal tissue with the RS model (OR<sub>q4 vs. q1</sub>=1.84, 95%CI 1.12-3.04). There was an elevated risk of IBC in those with higher senescence scores in both epithelial and adipose tissue compared with those with low senescence scores in both (IR epithelium-IR fat: OR<sub>q2-4 vs. q1</sub>=2.14, 95% CI 1.30-3.51; and IR epithelium-RS fat: OR<sub>q2-4 vs. q1</sub>= 2.24, 95% CI 1.15-4.35).</p><p><strong>Conclusions: </strong>This study suggests that nuclear senescence scores predicted by deep learning models in breast epithelial and adipose tissue can predict the risk of breast cancer development among women with BBD.</p>","PeriodicalId":49227,"journal":{"name":"Breast Cancer Research","volume":"27 1","pages":"37"},"PeriodicalIF":7.4000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11900263/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cellular senescence predicts breast cancer risk from benign breast disease biopsy images.\",\"authors\":\"Indra Heckenbach, Rita Peila, Christopher Benz, Sheila Weinmann, Yihong Wang, Mark Powell, Morten Scheibye-Knudsen, Thomas Rohan\",\"doi\":\"10.1186/s13058-025-01993-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Each year, millions of women undergo breast biopsies. Of these, 80% are negative for malignancy but some may be at elevated risk of invasive breast cancer (IBC) due to the presence of benign breast disease (BBD). Cellular senescence plays a complex but poorly understood role in breast cancer development and the presence or absence of these cells may have prognostic value.</p><p><strong>Methods: </strong>We conducted a case-control study, nested within a cohort of 15,395 women biopsied for BBD at Kaiser Permanente Northwest between 1971 and 2006. Cases (n = 512) were women who developed a subsequent invasive breast cancer (IBC) at least one year after the BBD biopsy; controls (n = 491) did not develop IBC during the same follow-up period. Using H&E-stained biopsy images, we predicted senescence based on deep learning models trained on replicative senescence (RS), ionizing radiation (IR), and various drug treatments. Age-adjusted and multivariable odds ratios (ORs) and 95% confidence intervals (CI) were estimated using unconditional logistic regression.</p><p><strong>Results: </strong>The RS- and IR-derived senescence scores for adipose tissue and the RS-derived score for epithelial tissue were positively associated with the risk of IBC (adipose tissue - RS model: OR<sub>q4 vs. q1</sub>=1.69, 95% CI 1.03-2.77, and IR model: OR<sub>q4 vs. q1</sub>=1.73, 95%CI 1.06-2.82; epithelial tissue- RS model: OR<sub>q4 vs. q1</sub>=1.53, 95% CI 1.05-2.22). The results were stronger among postmenopausal women and women with epithelial hyperplasia with/without atypia, and postmenopausal women also showed a positive association for stromal tissue with the RS model (OR<sub>q4 vs. q1</sub>=1.84, 95%CI 1.12-3.04). There was an elevated risk of IBC in those with higher senescence scores in both epithelial and adipose tissue compared with those with low senescence scores in both (IR epithelium-IR fat: OR<sub>q2-4 vs. q1</sub>=2.14, 95% CI 1.30-3.51; and IR epithelium-RS fat: OR<sub>q2-4 vs. q1</sub>= 2.24, 95% CI 1.15-4.35).</p><p><strong>Conclusions: </strong>This study suggests that nuclear senescence scores predicted by deep learning models in breast epithelial and adipose tissue can predict the risk of breast cancer development among women with BBD.</p>\",\"PeriodicalId\":49227,\"journal\":{\"name\":\"Breast Cancer Research\",\"volume\":\"27 1\",\"pages\":\"37\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11900263/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Cancer Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13058-025-01993-z\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13058-025-01993-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:每年有数百万妇女接受乳房活检。其中,80%为恶性肿瘤阴性,但由于存在良性乳腺疾病(BBD),一些人患浸润性乳腺癌(IBC)的风险可能升高。细胞衰老在乳腺癌的发展中起着复杂但鲜为人知的作用,这些细胞的存在或缺失可能具有预后价值。方法:我们进行了一项病例对照研究,在1971年至2006年期间,在Kaiser Permanente西北医院对15395名女性进行了BBD活检。病例(n = 512)是在BBD活检后至少一年发生浸润性乳腺癌(IBC)的女性;对照组(n = 491)在同一随访期间未发生IBC。使用h&e染色的活检图像,我们基于复制性衰老(RS)、电离辐射(IR)和各种药物治疗训练的深度学习模型预测衰老。使用无条件逻辑回归估计年龄调整和多变量优势比(ORs)和95%置信区间(CI)。结果:脂肪组织的RS和IR衍生的衰老评分以及上皮组织的RS衍生评分与IBC的风险呈正相关(脂肪组织- RS模型:ORq4 vs. q1=1.69, 95%CI 1.03-2.77, IR模型:ORq4 vs. q1=1.73, 95%CI 1.06-2.82;上皮组织- RS模型:ORq4 vs. q1=1.53, 95% CI 1.05-2.22)。结果在绝经后妇女和上皮增生伴/不伴异型增生的妇女中更为明显,绝经后妇女间质组织也与RS模型呈正相关(ORq4 vs. q1=1.84, 95%CI 1.12-3.04)。上皮组织和脂肪组织衰老评分较高的患者患IBC的风险高于两者衰老评分较低的患者(IR上皮组织-IR脂肪:ORq2-4 vs. q1=2.14, 95% CI 1.30-3.51;IR上皮- rs脂肪:ORq2-4 vs. q1= 2.24, 95% CI 1.15-4.35)。结论:本研究表明,通过乳腺上皮组织和脂肪组织的深度学习模型预测的核衰老评分可以预测BBD女性乳腺癌发展的风险。
Cellular senescence predicts breast cancer risk from benign breast disease biopsy images.
Background: Each year, millions of women undergo breast biopsies. Of these, 80% are negative for malignancy but some may be at elevated risk of invasive breast cancer (IBC) due to the presence of benign breast disease (BBD). Cellular senescence plays a complex but poorly understood role in breast cancer development and the presence or absence of these cells may have prognostic value.
Methods: We conducted a case-control study, nested within a cohort of 15,395 women biopsied for BBD at Kaiser Permanente Northwest between 1971 and 2006. Cases (n = 512) were women who developed a subsequent invasive breast cancer (IBC) at least one year after the BBD biopsy; controls (n = 491) did not develop IBC during the same follow-up period. Using H&E-stained biopsy images, we predicted senescence based on deep learning models trained on replicative senescence (RS), ionizing radiation (IR), and various drug treatments. Age-adjusted and multivariable odds ratios (ORs) and 95% confidence intervals (CI) were estimated using unconditional logistic regression.
Results: The RS- and IR-derived senescence scores for adipose tissue and the RS-derived score for epithelial tissue were positively associated with the risk of IBC (adipose tissue - RS model: ORq4 vs. q1=1.69, 95% CI 1.03-2.77, and IR model: ORq4 vs. q1=1.73, 95%CI 1.06-2.82; epithelial tissue- RS model: ORq4 vs. q1=1.53, 95% CI 1.05-2.22). The results were stronger among postmenopausal women and women with epithelial hyperplasia with/without atypia, and postmenopausal women also showed a positive association for stromal tissue with the RS model (ORq4 vs. q1=1.84, 95%CI 1.12-3.04). There was an elevated risk of IBC in those with higher senescence scores in both epithelial and adipose tissue compared with those with low senescence scores in both (IR epithelium-IR fat: ORq2-4 vs. q1=2.14, 95% CI 1.30-3.51; and IR epithelium-RS fat: ORq2-4 vs. q1= 2.24, 95% CI 1.15-4.35).
Conclusions: This study suggests that nuclear senescence scores predicted by deep learning models in breast epithelial and adipose tissue can predict the risk of breast cancer development among women with BBD.
期刊介绍:
Breast Cancer Research, an international, peer-reviewed online journal, publishes original research, reviews, editorials, and reports. It features open-access research articles of exceptional interest across all areas of biology and medicine relevant to breast cancer. This includes normal mammary gland biology, with a special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal covers preclinical, translational, and clinical studies with a biological basis, including Phase I and Phase II trials.